AngioDynamics Inc (STU:UG2) Stock News, Headlines & Updates
AngioDynamics Inc Stock News from GuruFocus
- 1
May 21, 2024
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18?? System
Business Wire • 5:00pm
May 06, 2024
AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18?? System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
Business Wire • 4:00pm
Apr 05, 2024
AngioDynamics Inc (ANGO) Q3 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
GuruFocus Research • 3:44pm
Q3 2024 AngioDynamics Inc Earnings Call Transcript
GuruFocus Research • 11:00pm
Apr 04, 2024
AngioDynamics Inc (ANGO) Posts Q3 Fiscal 2024 Results: A Mixed Performance Amidst Asset Divestiture
GuruFocus Research • 6:51am
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
Business Wire • 6:00am
Apr 01, 2024
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
Business Wire • 5:00pm
Mar 19, 2024
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
Business Wire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news